The Breast Implants Market is anticipated to witness significant growth in the coming years, driven by a surge in demand for cosmetic surgeries and an increasing prevalence of breast cancer.
The breast implant market is poised for significant growth, with a projected valuation of USD 3.96 billion by 2031. This translates to a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031, indicating a steady rise in market size from its 2023 value of USD 2.45 billion.
Download Free Sample Report of Breast Implants Market @ https://www.snsinsider.com/sample-request/1208
List of Breast Implants Companies Profiled in Report:
- AbbVie Inc.
- Allergan plc
- CEREPLAS
- Establishment Labs S.A.
- GC Aesthetics
- GROUPE SEBBIN SAS
- Guangzhou Wanhe Plastic Materials Co., Ltd.
- HansBioMed
- Laboratoires Arion
- Mentor Worldwide LLC
- Polytech Health and Aesthetics GmBH
- Sebbin
- Shanghai Kangning Medical Supplies Ltd.
- Sientra Inc.
Aesthetics and Reconstruction Fueling Breast Implant Market Expansion
Breast implant surgery has become increasingly popular in recent years, fueled by a growing emphasis on aesthetics. Women seeking to enhance their appearance significantly contribute to the breast implant market’s revenue. The FDA (Food and Drug Administration) in the United States permits breast augmentation procedures for women over 18 years of age.
On the other hand, the rising incidence of breast cancer is another critical factor propelling market growth. In severe cases, breast cancer treatment may involve mastectomy, a surgical procedure that necessitates the removal of the entire breast. Breast reconstruction surgery offers a viable option for women who have undergone mastectomies. This reconstructive procedure aims to restore the shape of the removed breast, and with a growing number of reconstruction cases, the demand for breast implants is anticipated to rise throughout the forecast period.
The American Society of Plastic Surgeons (ASPS) recognizes breast augmentation as one of the top five cosmetic procedures performed in the U.S. According to the ASPS, there were 279,143 breast augmentation procedures conducted in the U.S. alone in 2020. This substantial number of procedures is expected to accelerate the growth of the breast implant market in the years to come.
A Fight Against Cancer and the Pursuit of Beauty
Breast cancer’s alarming rise, with over 2.3 million diagnoses globally in 2020 (WHO), is a significant factor propelling the breast implant market. This is particularly true for regions like Asia, where breast cancer accounts for a substantial 22.9% of female cancers. Reconstruction surgeries for these patients require breast implants, creating a constant demand.
However, the market isn’t solely driven by medical necessity. A growing number of women are opting for breast augmentation procedures to enhance their appearance. Statistics from the International Society for Aesthetic Plastic Surgeons (ISAPS) reveal that the U.S. alone saw a staggering 193,073 breast augmentation procedures in 2020, topping the list of cosmetic surgeries. This rising demand for aesthetic improvement fuels the market alongside the need for breast cancer reconstruction.
Market players are actively contributing to this growth by investing in research and development for better implants. They’re also launching awareness campaigns (like Allergan Aesthetics’ digital campaign in June 2020) to educate patients and ensure responsible use of implants. The introduction of advanced implants with improved features further bolsters the market’s overall expansion.
Key Market Segments
By Product
- Silicone Breast Implants
- Saline Breast Implants
By Shape
- Round
- Anatomical
By Application
- Reconstructive Surgery
- Cosmetic Surgery
By End-Use
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
Have Any Query? Ask Our Experts @ https://www.snsinsider.com/enquiry/1208
Silicone Segment to Hold Major Share
These implants are silicone shells filled with a silicone gel that closely resembles human fat in consistency. This translates to a more natural look and feel, a critical factor for both breast augmentation and reconstruction procedures. Silicone implants are approved by the U.S. Food and Drug Administration (FDA) for breast augmentation in women 22 and over, and for reconstruction in all age groups. This versatility ensures they cater to a wider range of needs.
The market for silicone implants is constantly evolving. Manufacturers like GC Aesthetics Inc. are at the forefront, developing next-generation products like the PERLE implant with its innovative BioQ surface technology. These advancements further solidify the dominance of silicone implants.
North America to Dominate the Market
The prevalence of entertainment industries and a growing emphasis on self-awareness among women fuels the demand for breast augmentation procedures in North America. This translates to a significant market for implants used in these surgeries. Statistics speak for themselves: in the U.S. alone, breast augmentation ranked among the top five cosmetic surgeries in 2020, with over 193,000 procedures performed (American Society of Plastic Surgeons, 2020).
North America also faces a rising tide of breast cancer cases. GLOBOCAN 2020 reported a significant number of new diagnoses in the region, including the United States (253,465), Canada (28,026), and Mexico (29,929). This unfortunate reality translates to a constant need for breast reconstruction surgeries, which often rely on implants.
Regulatory Landscape Fosters Innovation: Regulatory bodies like the U.S. Food and Drug Administration (FDA) play a crucial role in market growth. New product approvals, exemplified by Mentor Worldwide LLC’s FDA clearance for the MENTOR Memory Gel BOOST implant in January 2022, pave the way for innovation and further fuel market expansion in North America.
Recent Developments
In September 2023, Mentor introduced Motiva Ergonomix, a new line of breast implants designed to provide a natural look and feel. These implants are made from a unique, softer silicone gel for improved comfort.
In June 2023, Silimed launched the Purethane Implant, an innovative implant made from polyurethane foam. This material offers greater comfort and superior resistance against ruptures compared to traditional silicone implants.
Key Takeaways from the Breast Implants Market Study
- The global breast implant market is expected to reach USD 3.96 billion by 2031, exhibiting a CAGR of 6.2% from 2024 to 2031.
- The rising demand for cosmetic procedures and breast cancer reconstruction surgery are the key growth drivers for the market.
- Silicone implants are anticipated to dominate the market due to their lifelike feel and aesthetic appeal.
- The economic slowdown and the Russia-Ukraine war are potential challenges that can hinder market growth.
- North America is expected to remain the dominant market due to the high prevalence of cosmetic surgeries and breast cancer.
- Advancements in technology and new product approvals are propelling the development of more efficient and improved breast implants.
Purchase Breast Implants Market Report @ https://www.snsinsider.com/checkout/1208
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Breast Implants Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Breast Implants Market Segmentation, By Product
Chapter 9 Breast Implants Market Segmentation, By Shape
Chapter 10 Breast Implants Market Segmentation, By Application
Chapter 11 Breast Implants Market Segmentation, By End-Use
Chapter 12 Regional Analysis
Chapter 13 Company profile
Chapter 14 Competitive Landscape
Chapter 15 Use Case and Best Practices
Chapter 16 Conclusion
Continued…
Other Trending Report
AI in Cancer Diagnosis Market Outlook
Healthcare Automation Market Outlook
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 | +91-7798602273 (IND)
